Ablation devices are at present used in varied healthcare areas such as orthopedic, dermatology, cardiology, gynecology, neurology and several others. Global growth in preference for minimally invasive procedures is helping drive the demand for ablation devices. Major factors supporting the rise in ablation treatments include groping preference from senescent patients andhigh prevalence of chronic diseases.
This report on hematopoietic stem cells transplantation market studies various transplant types and applications. Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases.
This report on global breast cancer treatment market studies various drugs used for treatment of breast cancer along with pipeline analysis of upcoming potential drugs. Breast cancer is the second most common cancer observed in women worldwide, accounting for around 17% of all female cancers, making the disease exceptionally prevalent. The predictions shared by GLOBOCON in 2012 suggests that the incidence rate of breast cancer in 2012 was for ages= 65 was 503, 158 and by 2020 it is anticipated that ages=65 will be 643,442.
Growth in incidence of rectal, GI and colon cancer and flourishing trend of cancer screening through genetic testing are the prime factors allowing the growth of in vitro colorectal cancer screening market. Favorable government guidelines and regulation for increasing awareness in the general population and supporting the adoption colon cancer screening also facilitate the global demand for minimally invasive screening tests that use genetic biomarkers and DNA for risk determination.
Home Healthcare Market is Expected to Grow at 6.5% by 2033. Older adults are majorly benefited with home healthcare as it helps them to stay independently for as long as possible in an injury or illness. Home healthcare covers a broad range of services and can possess capability of delaying the need for long-term nursing home care. According to market experts, in the U.S. currently 12 million patients and more than 428 million patient visits each year out of which 70% are using home healthcare services aged 65 and older.
Biopreservation Market is Expected to Grow at 9.5% by 2033. The process of applying natural or controlled antimicrobials to preserve food materials for extending its shelf life is known as biopreservation. The biopreservation process is usually carried out with the help of lactic acid bacteria (LAB) as they are inhibitory to microbes responsible for food spoilage. The key agents applied in biopreservation process are lactic acid bacteria, yeast, and bacteriophages.
Biomarker based diagnostics have already offered great advanced in the past decade in the field of cancer diagnosis, prognosis, staging and therapy selection. However, tissue-based detection approach produces a major drawback in terms of invasion for sample collection.
Pain management is a branch of medical science which eases the suffering of the patients who have chronic pain. Acute pain has sudden onset of action whereas chronic pain usually lingers for a longer duration which causes unpleasant aggravation in patients which leads to need for its management. Various devices are used to manage chronic pain like Electrostimulation devices, Radiofrequency ablation devices, Infusion pumps and Neurostimulation devices. These devices block the pain gate mechanism to block the passage of pain signals to the brain.
The pharmacovigilance (phv) market is anticipated to grow at a compound annual growth rate of 13.5% for the forecasted period (2025 – 2033). As the world's population ages, chronic diseases have increased; and more adverse drug reactions mean more pharmacovigilance.
The oncology drugs market is a critical segment of the pharmaceutical industry, providing innovative solutions for the treatment of cancer. The market is driven by the increasing prevalence of cancer worldwide, advancements in technology, and the emergence of personalized medicine. The oncology drugs market is a highly competitive and dynamic market, with many companies focusing on the development of novel therapies to treat cancer. One of the primary drivers of the oncology drugs market is the increasing prevalence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, accounting for approximately 9.6 million deaths in 2018. The rising incidence of cancer has led to an increased demand for innovative oncology drugs, driving the growth of the market.
The global oncology drugs market is expected to grow at a CAGR of 13% during the period of 2023 to 2031. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the oncology drugs market is the increasing use of immunotherapy. Immunotherapy involves the use of drugs that stimulate the body's immune system to attack cancer cells. Immunotherapy has shown promising results in the treatment of several types of cancer, including melanoma, lung cancer, and bladder cancer. The development of immunotherapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the oncology drugs market. Another trend in the oncology drugs market is the increasing focus on precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of the oncology drugs market.
The increasing focus on targeted therapies is also driving the growth of the oncology drugs market. Targeted therapies are drugs that are designed to target specific molecules that are involved in the growth and spread of cancer cells. Targeted therapies can be more effective than traditional chemotherapy, as they have fewer side effects and are more specific in their action. The development of targeted therapies requires the use of advanced drug discovery technologies, which has contributed to the growth of the oncology drugs market.
The increasing use of combination therapies is driving the growth of the oncology drugs market. Combination therapies involve the use of two or more drugs to treat cancer. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the oncology drugs market. The oncology drugs market is a critical segment of the pharmaceutical industry, providing innovative solutions for the treatment of cancer. The increasing prevalence of cancer worldwide, advancements in technology, and emerging trends in immunotherapy, precision medicine, targeted therapies, and combination therapies are expected to drive the growth of the oncology drugs market. As the demand for new and effective therapies continues to increase, the oncology drugs market is expected to remain a critical component of the pharmaceutical industry in the coming years. Companies that provide oncology drugs and related services are well-positioned to capitalize on this growing market.
